Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Proactive research analyst says Tiziana Life Sciences "moving forward quite nicely"

By: News Direct
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

--News Direct--

Proactive research analyst Robin Davison speaks to Thomas Warner after publishing a 2023 Clinical Outlook for clinical stage biotechnology company Tiziana Life Sciences Ltd (NASDAQ: TLSA). He gives his take on what the market can expect from the business this year, saying that it is now "moving forward quite nicely."

Contact Details

Proactive UK Ltd

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

View source version on newsdirect.com: https://newsdirect.com/news/proactive-research-analyst-says-tiziana-life-sciences-moving-forward-quite-nicely-546792176

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  249.70
+1.20 (0.48%)
AAPL  263.40
-3.03 (-1.14%)
AMD  278.26
+20.14 (7.80%)
BAC  53.51
-0.81 (-1.49%)
GOOG  332.77
-1.70 (-0.51%)
META  676.87
+5.29 (0.79%)
MSFT  420.26
+9.04 (2.20%)
NVDA  198.35
-0.52 (-0.26%)
ORCL  178.34
+8.53 (5.02%)
TSLA  388.90
-3.05 (-0.78%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.